Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial

Jorik Nonnekes; Alexander Geurts

doi:10.1002/mds.28659

Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial

Movement Disorders ◽

10.1002/mds.28659 ◽

2021 ◽

Vol 36 (7) ◽

pp. 1733-1733

Author(s):

Jorik Nonnekes ◽

Alexander Geurts

Keyword(s):

Botulinum Toxin ◽

Randomized Trial ◽

Hereditary Spastic Paraplegia ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Spastic Paraplegia ◽

Letter To The Editor

Download Full-text

Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia — The SPASTOX Trial

Movement Disorders ◽

10.1002/mds.28523 ◽

2021 ◽

Author(s):

Fabricio Diniz de Lima ◽

Ingrid Faber ◽

Katiane R. Servelhere ◽

Maria Fernanda R. Bittar ◽

Alberto R.M. Martinez ◽

...

Keyword(s):

Botulinum Toxin ◽

Randomized Trial ◽

Hereditary Spastic Paraplegia ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Spastic Paraplegia

Download Full-text

Reply to: “Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial”

Movement Disorders ◽

10.1002/mds.28658 ◽

2021 ◽

Vol 36 (7) ◽

pp. 1734-1735

Author(s):

Fabricio Diniz de Lima ◽

Marcondes C. França

Keyword(s):

Botulinum Toxin ◽

Randomized Trial ◽

Hereditary Spastic Paraplegia ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Spastic Paraplegia

Download Full-text

Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia

Journal of Rehabilitation Medicine ◽

10.2340/16501977-2556 ◽

2019 ◽

pp. 0 ◽

Cited By ~ 4

Author(s):

B van Lith ◽

J den Boer ◽

B van de Warrenburg ◽

V Weerdesteyn ◽

A Geurts

Keyword(s):

Botulinum Toxin ◽

Hereditary Spastic Paraplegia ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Spastic Paraplegia

Download Full-text

Effectiveness of botulinum toxin type a (boNT-A) in long-term treatment of hereditary spastic paraplegia in children: Review of a series of 63 cases

Toxicon ◽

10.1016/j.toxicon.2016.11.087 ◽

2016 ◽

Vol 123 ◽

pp. S30-S31

Author(s):

Mar Garcia-Romero ◽

Mercedes Martinez-Moreno ◽

Samuel Ignacio Pascual-Pascual

Keyword(s):

Botulinum Toxin ◽

Hereditary Spastic Paraplegia ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Term Treatment ◽

Spastic Paraplegia ◽

Long Term Treatment

Download Full-text

Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: A study in patients with hereditary spastic paraplegia

Journal of Rehabilitation Medicine ◽

10.2340/16501977-1909 ◽

2015 ◽

Vol 47 (2) ◽

pp. 147-153 ◽

Cited By ~ 9

Author(s):

M Niet ◽

S Bot ◽

B Warrenburg ◽

V Weerdesteyn ◽

A Geurts

Keyword(s):

Botulinum Toxin ◽

Hereditary Spastic Paraplegia ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Spastic Paraplegia ◽

Calf Muscles

Download Full-text

Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients

Clinical Rehabilitation ◽

10.1177/0269215511405080 ◽

2011 ◽

Vol 25 (12) ◽

pp. 1119-1127 ◽

Cited By ~ 29

Author(s):

Stefano Carda ◽

Marco Invernizzi ◽

Alessio Baricich ◽

Carlo Cisari

Keyword(s):

Botulinum Toxin ◽

Randomized Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Stroke Patients ◽

Single Blind

Download Full-text

Inappropriate citations used to describe the pharmacology of botulinum toxin type A preparations in clinical use and Response to letter to the editor by Zakine et al. Ongoing discussion on the pharmacology of botulinum toxin type A formulations: conclusions of adult spasticity consensus are correct in this respect

Journal of Rehabilitation Medicine ◽

10.2340/16501977-0386 ◽

2009 ◽

Vol 41 (7) ◽

pp. 591-592

Author(s):

B Zakine ◽

AM Pickett ◽

P Maisonobe

Keyword(s):

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Clinical Use ◽

Letter To The Editor

Download Full-text

Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial

Clinical Orthopaedics and Related Research ◽

10.1007/s11999-016-5018-6 ◽

2016 ◽

Vol 474 (12) ◽

pp. 2705-2711 ◽

Cited By ~ 4

Author(s):

Hoon Park ◽

Soowan Shin ◽

Han Sol Shin ◽

Hyun Woo Kim ◽

Dong Wook Kim ◽

...

Keyword(s):

Botulinum Toxin ◽

Randomized Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Femoral Lengthening ◽

Valuable Adjunct

Download Full-text

CORR Insights®: Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial

Clinical Orthopaedics and Related Research ◽

10.1007/s11999-016-5082-y ◽

2016 ◽

Vol 474 (12) ◽

pp. 2712-2713

Author(s):

Stuart A. Green

Keyword(s):

Botulinum Toxin ◽

Randomized Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Femoral Lengthening ◽

Valuable Adjunct

Download Full-text

Letter to the Editor: Evaluation of Efficacy of Corticosteroid and Corticosteroid Combined with Botulinum Toxin Type A in the Treatment of Keloid and Hypertrophic Scars—A Meta-Analysis

Aesthetic Plastic Surgery ◽

10.1007/s00266-021-02539-2 ◽

2021 ◽

Author(s):

Shuai Yue ◽

Mengran Ju

Keyword(s):

Botulinum Toxin ◽

Meta Analysis ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Hypertrophic Scars ◽

Letter To The Editor

Download Full-text